TranS1 Completes Head-to-Head Fusion Rate Study

TranS1 completed its first head-to-head retrospective study comparing its proprietary AxiaLIF pre-sacral interbody fusion procedure to anterior lumbar interbody fusion.

Advertisement

Two independent spine surgeons evaluated 96 total patients at two year or greater follow up with thin slice CT scans. The combined review of both surgeons demonstrated improved fusion rates with AxiaLIF over ALIF, though the difference in the rates was not statistically significant. Further, the AxiaLIF cohort experienced no serious adverse events, compared with the ALIF cohort, which reported two serious adverse events.

The study will be submitted for publication.

More Articles on Orthopedic Devices:

Spinal Elements Launches Ti-Bond

Exactech Announces 2Q Revenue of $55.2M, Up 7%

DJO Global 2Q Net Sales Reach $286M, a 2.9% Increase

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.